Airain ltd - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 82 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Airain ltd ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$290,000
-38.6%
21,551
-44.8%
0.02%
-31.0%
Q1 2015$472,000
+33.7%
39,044
-3.8%
0.03%
+20.8%
Q3 2014$353,000
-8.8%
40,572
+14.8%
0.02%
-25.0%
Q2 2014$387,000
-15.7%
35,343
-31.2%
0.03%
-60.5%
Q1 2014$459,00051,3950.08%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders